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ABSTRACT 
Introduction: Chronic Hepatitis B virus (HBV) and Hepatitis C virus (HCV) infections are common 
causes of chronic liver disease. In the Asia-Pacific region, mother to infant transmission (vertical trans-
mission) is the most common mode for HBV. On the other hand, perinatal HCV transmission is relative-
ly low. This epidemiological study assessed the prevalence of HBV and HCV among pregnant women 
delivering in a tertiary referral centre in Brunei Darussalam. Data also provided information on Human 
Immunodeficiency Virus (HIV) and syphilis infection. Materials and Methods: All patients who deliv-
ered over a 12-month (January 2011 to December 2011) period were included. Patients were routinely 
tested for HBV, Hepatitis B surface antigen (HBsAg), HIV and Venereal Disease Reference Laboratory 
(VDRL). In-patients (n=125) found to be HBsAg positive, or who did not have any ante-natal care test-
ing, were tested for Hepatitis Be Antigen (HBeAg) and Anti Hepatitis Be Antibody (Anti-HBe Ab) and 
anti-HCV). Results: The overall prevalence of HBsAg positive was 1.02%, significantly higher among 
the Chinese (2.4%), indigenous (4.0%) and expatriates (1.5%) than among the Malays (0.8%) 
(p<0.05 for trend). Among those with HBsAg positive, 22% were found to be positive for HBeAg. The 
most common identified risk factor for patients was family history of hepatitis B infection (37%). Two 
patients were positive for HIV (0.04%) and six for VDRL (0.11%). No patient was found to be positive 
for HCV. Conclusions: The HBV infection rates among our patients are lower than previously reported 
but the ethnic differences remain. Of those found to be positive, a fifth was positive for HBeAg. No pa-
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INTRODUCTION 
Infections are important causes of morbidity 
and mortality especially in the developing and 
underdeveloped nations. Modes of transmis-
sion are generally dependent on the organ-
isms and systems involved. Perinatal trans-
mission remains an important mode of trans-
mission of infections. Of the infections trans-
missible from mother to child, Hepatitis B Vi-
rus (HBV) and Human Immune-Deficiency 
Virus (HIV) are the two most common world-
wide, especially in developing countries where 
the prevalence rates for these infections are 
high. 1, 2 The risk of HBV transmission is as 
high as 90% if the mother is positive for the 
Hepatitis B envelope Antigen (HBeAg) but is 
between 10 to 20% if negative. 3 Transmission 
of Hepatitis C virus (HCV) during the perinatal 
period can also occur but is generally much 
lower. 4 Perinatal transmission can be reduced 
through routine antenatal screening as it al-
lows early detection and implementation of 
appropriate measures and treatment.   
 
 A previous study conducted in our 
local setting more than two decades ago 
showed that the prevalence of HBV infection 
among pregnant women was 3.2% with ethnic 
differences. 5 This present study assesses a) 
the prevalence of the infections included in 
routine antenatal screening, and HCV infection 
among Hepatitis B surface Antigen (HBsAg) 
positive pregnant women admitted to the la-
bour ward of the Raja Isteri Pengiran Anak 
Saleha (RIPAS) Hospital, Brunei Darussalam, 
and b) the presence of relevant risk factors 
associated with HBV infections. 
dles five to six thousand of these deliveries.  
 
Patients: Pregnant women attending the an-
tenatal clinics in Brunei Darussalam are rou-
tinely screened for HBV, Syphilis (VDRL Test), 
and HIV. Appropriate measures were taken if 
a patient was found to be positive for any of 
these conditions and the patient is referred to 
the appropriate specialties for further evalua-
tions and measurement. Post-delivery, all in-
fants are given hepatitis B vaccination at 0, 1 
and 6 months. Hepatitis B immunoglobulin G 
(HBIgG) is only given to infants of Hepatitis B 
seropositive mothers after consultation with 
the paediatricians. 
 
 All pregnant women admitted to the 
labour ward of RIPAS hospital for delivery in a 
period of 12 months (1st January 2011 to 31st 
December 2011) were included in this pro-
spective study. The patients’ antenatal rec-
ords were checked to assess their HBV status. 
Patients who were positive for Hepatitis B 
were also checked for HCV. Tests for both 
HBV and HCV were arranged for patients who 
did not have any antenatal screening prior to 
admission.  
 
 Serological tests evaluated included 
HBsAg, HBeAg, anti-HBe, Hepatitis B core an-
tibody (anti-HBc) and hepatitis C antibody 
(anti-HCV). All tests were performed with a 
chemiluminescent immunoassay using the 
Roche Cobas 6000 platform (sensitivity 
>95%, specificity >95%). Anti-HCV positive 
samples were confirmed by Serodia manual 
test (agglutination test) and Innolia (Western 
Blot test). 
 
Data collection: Patient’s age, gravidity, par-
ity, marital status and occupation were ob-
HTWE et al. Brunei Int Med J. 2013; 9 (4): 221 
MATERIALS AND METHODS 
Setting: RIPAS Hospital is a 550 bed hospital 
and is the largest tertiary referral hospital in 
Brunei Darussalam. It handles all complicated 
pregnancies in the country as well as routine 
deliveries. Annually, there are almost 7,000 
deliveries in Brunei and RIPAS hospital han-
tained from the patient’s antenatal card. Addi-
tional data were collected after informed con-
sent from patients who were positive for HBV 
or HCV. Risk factors such as previous blood 
and blood product transfusion, intravenous 
drug use, tattooing, family history of hepati-
tis, history of jaundice, surgery, dental sur-
gery or interventions were inquired using a 
self-report questionnaire. Information relating 
to husband/partners such as age, occupation, 
intravenous drug use, history of jaundice and 
number of marriages were also requested.  
 
Data analyses: Data were entered using Mi-
crosoft Excel spreadsheet software and were 
later transferred into SPSS (Chicago, Il, USA) 
Version 17.0 for analysis. Data analysis in-
cludes descriptive analysis and analysis of 
estimation of proportions. 
Total deliveries Hepatitis B seropositive HIV positive Syphilis (VDRL) 
 5,288 54 (1.02%)  2 (0.04%)  6 (0.11%) 
  Ethnic groups 
 
Malays Chinese Indigenous  Expatriates Total 
HBsAg (+ve) 36 (0.8%) 3 (2.4%) 5 (4%) 10 (1.5%) 54 (1.02) 
Total 4,376 124 125 663 5,288 
which included two cases of HIV positivity 
(0.04%) and six cases of VDRL positive 
(0.11%).  
  
 The prevalence of HBsAg positive 
among the different racial groups is shown in 
Table 2. The rate was higher among the In-
digenous group followed by the Chinese. 
 
 Of the patients found to be positive 
for HBsAg positive, 22% (n=12) were positive 
for HBeAg, 72% (n=39) were anti-HBe posi-
tive and 80% (n=43) were anti-HBc positive. 
 
 Of the 52 patients, 65% were in the 
20 to 34 year age group and 35% were 35 
years and above. Fifteen percent were nullipa-
rous. Three (5.5%) were single and 51 
(94.5%) were married: five more than once 
(four twice, one three times).  
 
 The risk factors for HBV infections are 
shown in Table 3. Twenty percent were not 
aware of their family’s HBV status. Only one 
husband had a history of hepatitis. Five were 
unaware of their husbands’ status. 
 
 Among the 125 women who tested 
positive for HBsAg or had risk factors for 
blood borne infections, none were found to be 
Table 2: Prevalence of Hepatitis B (HBsAg +ve) among the different ethnic groups. 
Table 1: Prevalence of Hepatitis B, HIV and VDRL sero-positivity. 
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RESULTS 
Over the year period, there were a total of 
5,288 deliveries with a majority Malays, con-
sistent with the national population racial dis-
tribution. 
 
 Of all the patients surveyed, 71 
(1.34%) did not have any antenatal care or 
screening prior to admission. The overall posi-
tivity rate for the screening was 1.2% (n=62) 
Risk factors N (%) 
Family history of Hepatitis 20 (37) 
Surgery 15 (28) 
History of blood transfusion 9 (16.7) 
Dental procedure 7 (13) 
Jaundice 4 (7) 
Tattoo 1 (2) 
Intravenous drug use 0 (0) 
No antenatal care 2 (4) 
DISCUSSION 
Antenatal screening is important as it allows 
detection of any mother to child transmissible 
infections. This allows measures to be institut-
ed for expectant mothers and children, and 
public health measures such as contact trac-
ing. Of the infections routinely screened, HBV 
and HIV are the most important as the perina-
tal transmission rates are high for these two 
infections. Furthermore, these two infections 
are common in certain geographical regions 
and population groups, hence increasing the 
risk of perinatal transmissions.  
 
 Globally, an estimated two billion peo-
ple have been exposed to the HBV with an 
estimated 350-400 million having chronic HBV 
infection. 1, 6 High endemic regions (5-20% 
carrier rate) include the Asia-Pacific regions, 
the Amazon Basin, Alaskan natives, Eastern 
Europe, Middle East and Africa. Low endemic 
regions (1-4% carrier rate) include developed 
nations such as the North America, Western 
Europe and Australia. 7 While 95% of infec-
tions acquired during adulthood are cleared, 
only 10% of neonates and children clear the 
initial infection, thus placing them at higher 
lifetime risk of chronic liver diseases and the 
associated complications. 8 In the Asia-Pacific 
Table 3: Risk factors for Hepatitis B.  
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region, HBV is an important cause of death 
through liver failure and hepatocellular carci-
noma. Therefore, it is especially important to 
ensure that all pregnant women in the en-
demic regions are screened, so that preven-
tive measures can be instituted. In Taiwan, 
introduction of the national vaccination pro-
gramme led to significant reduction of the in-
cidence of hepatocellular carcinoma in chil-
dren. 9 
 
 In our study, we showed that the 
prevalence of HBV was 1.02%, significantly 
higher among the indigenous, Chinese and 
the other groups compared to the Malays. 
Compared to a previous study carried out al-
most three decades ago in our local setting, 
the infection rate has significantly dropped 
among pregnant women (p<0.05): Sebastian 
et al. reported a prevalence of 3.2% among 
1,267 pregnant women who attended the an-
tenatal clinic of a district general hospital in 
1989. 5 The ethnic differences in the preva-
lence of HBV in both studies remain. Since 
then, there had been no further study looking 
at HBV infection among this group of patients. 
Our findings are not unexpected given the 
general improvement of healthcare 
(vaccination was introduced in 1984 for the 
high risk group and universal vaccination 
started 1988 in Brunei Darussalam) and im-
proved standard of living. Declining infection 
rates among blood donors in our local setting 
have been reported. 10 Not unexpectedly, eth-
nic differences were also seen among blood 
donors with the Malays having the lowest 
prevalence.  
 
 Our rate is noticeably lower or compa-
rable to the rates reported from other devel-
oping countries: Iran (6.5%) 11, Sudan 
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(5.6%) 6, Oman (7.1%), Qatar (1%), United 
Arab Emirates (1.5%) 12, rural Bangladesh 
(0.4%) 13 and Pakistan (1.57%). 7 A study 
from Ipoh, Malaysia reported a rate of 1.35%. 
14 To date, there are no recent published data 
for many parts of the Southeast Asian region. 
An older study from Manila, Philippines report-
ed a prevalence of 7.6%. 15 However, the cur-
rent rate is likely to be lower. Not unexpect-
edly, our rate is much higher than the rates 
reported from developed countries. The rates 
reported in the United States in 2003 varied 
across the four regions surveyed; white non-
Hispanic (0.60%), black non-Hispanics 
(0.97%), Hispanics (0.14%) and Asians 
(5.79%). 8 Similar low rates have been re-
ported in the other Western developed na-
tions. 
 
 Among our patients who were HBsAg 
positive, 20% were positive for HBeAg, a tra-
ditional marker for active replication. 16 Based 
on our result, it is suggested that 20% of HBV 
positive patients are considered highly infec-
tious and this represents a group for which 
additional steps need to be taken to reduce 
the risk of perinatal transmission. With the 
current understanding, HBV DNA is now a 
more important test to assess infectivity as 
even HBeAg negative status can be associated 
with high viral count. 16 
 
 Similar to HBV, HIV infection is still a 
major public health issue in many parts of the 
world including some Southeast Asian nations. 
In Brunei Darussalam, HIV infection is still 
uncommon but there has been a steady slow 
increase in case detection. 10 In our study, we 
only detected two cases. Despite the low yield 
and overall low prevalence of HIV, screening 
is important as effective measures to reduce 
 Unlike HBV and HIV, perinatal trans-
mission of HCV is relatively low and is report-
ed to be between 3 and 5%. 17, 18 However, 
the risk is much higher in the presence of HIV 
co-infection. Given its relatively low preva-
lence in pregnant women and the cost-
ineffectiveness of screening, HCV screening 
has not been included in the antenatal screen-
ing panel. This is in line with policies from the 
United Kingdom 18, United States 19 and Aus-
tralia. 20 However, perinatal transmission of 
HCV can occur. Importantly, patients with 
HCV have been shown to be at higher risk for 
baby born preterm, low birth weight and con-
genital anomalies making interventions for 
future pregnancies important. In our study, 
we did not find any case positive for HCV. De-
spite this, testing is still probably useful in 
patients with risk factors such as a previous 
history of intravenous drug use, abnormal 
liver profiles, history of receiving blood prod-
ucts before the HCV screening, those positive 
for HIV or who have partners known to be 
HCV positive. 
 
 Among the only non-viral infections 
screened during the antenatal period, syphilis 
has now become extremely rare in developed 
and many developing countries. However, 
screening remains important as intrauterine 
infection is associated with foetal abnormali-
ties and significant comorbidities. Further-
more, there are also effective treatments. In 
our setting, the prevalence rate of VDRL posi-
tivity was 0.11%, again significantly lower 
than the rate reported in the previous local 
study. 5 
 
 Overall, our results suggest that prev-
alence of HBV and syphilis infections are de-
creasing in our local setting. The prevalence 
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of HIV remains low but this will require con-
tinued surveillance. Encouragingly, no HCV 
was detected among the small subset of pa-
tients tested. This is probably a reflection of 
the declining prevalence of HCV in the general 
population according to a blood donor study. 
10 Despite the number being low, it is a con-
cern that 1.3% did not have any antenatal 
screening. Of these, two patients were found 
to be positive for HBV. While the overall result 
is an indication that the current system is 
working, more needs to be done to achieve 
100% antenatal registration.  
 
 In conclusion, our study showed that 
HBV infection is still the most common infec-
tion detected in antenatal screening, lowest 
among the Malays. A fifth was positive for 
HBeAg. The most common risk factor is still a 
positive family history of HBV infection. Only 
two cases of HIV were detected and none for 
HCV. Overall, our rates are significantly lower 
than the rates reported more than two dec-
ades ago from another district but the ethnic 
differences remain for HBV infection.  
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Brunei Darussalam - Healthcare in Pictures 
Newspaper clipping showing the Brunei delegates at the 1989, 7th World Transplant Games 
that was held in Singapore. The first delegate is Dato Sherlock Chin (Renal Specialist), one the 
historical pioneers (to be featured in a future issue of BIMJ). 
